Clinical Trial Update: Efficacy and Safety of Olanzapine for the Treatment of Nausea and Vomiting in Palliative Cancer Care [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating olanzapine for nausea and vomiting in palliative cancer care; efficacy and safety results not disclosed in the provided snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End Stage Cancer
• Nausea
• Vomiting

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: Khon Kaen University | Conditions: Nausea, Vomiting | Phase 2 | Status: UNKNOWN